Development and validation of the Oxford Benchmark Scale for Rating Vaccine Technologies (OBSRVT), a scale for assessing public attitudes to next-generation vaccine delivery technologies.
Kantor J. et al, (2025), Hum Vaccin Immunother, 21
Influential drivers of the cost-effectiveness of respiratory syncytial virus vaccination in European older adults: a multi-country analysis
Li X. et al, (2025), BMC Medicine, 23
Respiratory syncytial virus hospitalisation by chronological month of age and by birth month in infants
Guo L. et al, (2025), Nature Communications, 16
Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development
Siegal EZ. et al, (2025), npj Vaccines, 10
Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccines.
Murray SM. et al, (2025), Sci Immunol, 10
Immunogenicity and Safety of ChAdOx1 nCoV-19 (AZD1222) as a Homologous Fourth-Dose Booster: A Substudy of the Phase 3 COV003 Trial in Brazil
Costa Clemens SA. et al, (2025), Mayo Clinic Proceedings Innovations Quality and Outcomes, 9
A vaccine emergency – when to overrule parental refusal of vaccination at birth for prevention of vertical transmission of hepatitis B virus?
Wilkinson D. and SAVULESCU J., (2025), Archives of Disease in Childhood
Salmonella Typhi gut invasion drives hypoxic immune subsets associated with disease outcomes.
Bossel Ben-Moshe N. et al, (2025), Nat Commun, 16
Age differences in immunity to human seasonal coronaviruses and the immunogenicity of ChAdOx1 nCoV-19 (AZD1222).
Belij-Rammerstorfer S. et al, (2025), EBioMedicine, 118
Prediction and characterisation of the human B cell response to a heterologous two-dose Ebola vaccine.
O'Connor D. et al, (2025), Nat Commun, 16
Antibiotic use attributable to RSV infections during infancy - an international prospective birth cohort study
Hak SF. et al, (2025), Journal of Antimicrobial Chemotherapy, 80, 1803 - 1812
Longitudinal kinetics of the viral infection biomarker 3'-deoxy-3',4'-didehydro-cytidine in SARS-CoV-2, influenza A virus and RSV human challenge models.
Mehta R. et al, (2025), Npj Viruses, 3
Respiratory viral detection in children hospitalized with pneumonia during periods of major population disruptions in Nepal, 2014-2018.
Shrestha S. et al, (2025), J Pediatric Infect Dis Soc
The waning of maternal measles antibodies: a multi-country maternal-infant seroprevalence study.
Tiley KS. et al, (2025), J Infect
Adenoviral-vectored vaccine against Bordetella pertussis fimbrial antigen induces partial protection in a mouse model
Dierig A. et al, (2025), Vaccine X, 24
The TyphiNET data visualisation dashboard: unlocking Salmonella Typhi genomics data to support public health.
Dyson ZA. et al, (2025), Genome Med, 17
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine
Dold C. et al, (2025), Science Translational Medicine, 17
Consultation report - considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries.
Ibarz-Pavon AB. et al, (2025), Vaccine, 56